Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Number: 150473720 The Hematopoietic (Stem) Cell Transplant Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the largest and most experienced pediatric stem cell
-
-in-3d-stem-cell-derived-human-organ-models/t11589 Where to apply Website https://www.ceitec.eu/protein-in-cell-nmr-spectroscopy-in-3d-stem-cell-derived-… Requirements LanguagesENGLISHLevelGood
-
will continue to investigate human brain development with a focus on stem cell lineages and synaptic diversity. See https://scholar.google.com/citations?user=09RosEoAAAAJ (link is external) for a
-
Center for Advancement of Blood Cancer Therapies (CABCT) (https://icahn.mssm.edu/research/cabct ). The successful candidate will work on projects involving human induced pluripotent stem cells (iPSCs) and
-
> Scope: Fulltime >Temporary: 3 years >Remuneration: TV-L 13 > Start: 01.03.2026 For the Institut of Molecular Medicine we are looking for a Postdoctoral Researcher Stem Cell Niche Biology and
-
written English Demonstrated expertise in one or more of the following areas: genome integrity, stem cell culture, quantitative and live-cell microscopy, or bioinformatics We offer Two-year postdoc position
-
scholar in hematology, stem cell biology, and cancer biology to work in the laboratory of Professor Asiri Ediriwickrema in the Division of Hematology at Stanford University. This research opportunity will
-
send the following materials in a single PDF to Rachel McGowan (rmcgowan@stanford.edu(link sends e-mail) ) with the subject line Postdoctoral Application – Stem Cell Biologist: Does this position pay
-
single PDF to Rachel McGowan (rmcgowan@stanford.edu (link sends e-mail) ) with the subject line Postdoctoral Application – Stem Cell Biologist: Does this position pay above the required minimum
-
well as at the Faculty of Health and Medical Sciences: https://healthsciences.ku.dk/research/corefacilities/. Driving Discoveries towards Stem Cell-Based Therapies and Regenerative Medicine reNEW is committed